跳至主要内容
临床试验/ACTRN12624000519550
ACTRN12624000519550尚未招募Unknown

Efficacy of Early Notification of Low and high Inpatient glycaemia with a Glucose Hospital Telemetry System: the ENLIGHTS RCT

Melbourne Health0 个研究点目标入组 292 人开始时间: 2024年4月26日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
292

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Non-critical care adult inpatients
  • Diabetes mellitus (any aetiology) treated with multiple daily injections of insulin
  • Admitted under the Endocrinology, Diabetic Foot, Nephrology units on the study ward
  • Anticipated length of stay 3 days or greater

排除标准

  • Insulin pump use
  • Scheduled for any MRI scan in next 72 hours, or CT scan of the same region where CGM sensor is located
  • Receiving hydroxyurea
  • Receiving peritoneal dialysis
  • Palliative care
  • Current active inpatient CGM use
  • Inability to give informed consent
  • Unwilling/unable to wear CGM for duration of the study

研究者

相似试验